This blog category contains posts related to ADHD research and other reports in the news.
Meet a powerful player in the “How Can I Get my ADHD Medication” game: Pharmacy Benefit Managers (PBMs). Few consumers know about them. Yet, they represent a huge and growing factor in limiting access to
As the U.S. patent for Vyvanse expired August 2023, the FDA cleared 14 manufacturers to produce Vyvanse generics. It might take several months for a significant number of consumers to access these Vyvanse generics. At
ADHD diagnosis rates have increased in the UK, but ADHD is still “underdiagnosed.” That’s according to the Royal Pharmaceutical Society. Recent hard data on ADHD diagnosis and prescribing in the United Kingdom paints a clear
The generic drugs industry makes headlines this month. That’s thanks to the investigations of journalist Katherine Eban. She is the author of Bottle of Lies: The Inside Story of the Generic Drug Boom. Generic drugs are
Okay, the headlines this week may not come as news to us. But, following the recent ADHD Hall of Shame entry, science-based reportage comes as welcome relief. The following news sources, among others, report the latest study by NIDA Director Nora Volkow and colleagues showing that, well, ADHD is real. Read all about it.
If you’re like me, you get discouraged by ADHD naysaying in the media. That it is a condition that doesn’t exist, a Big Pharma invention. That individuals with ADHD—or their parents—are seeking the easy way
The topic here is prescription Adderall. Specifically: Adderall is too often prescribed badly. Adderall effects on personality can include irritability, anger, lowered empathy, and self-awareness. Moreover, reckless prescribing patterns have intensified public and political
This post explores FAA policy guidelines on ADHD. Specifically, is it possible to be a commercial pilot while having ADHD and taking medications now—or at any time in the past—to treat ADHD symptoms? Originally published
Concerta manufacturer Janssen officially ended availability of its authorized-generic mid-January 2023, through its Patriot subsidiary. In this post, I explain what this might mean for Concerta users. I’ll also touch upon the concurrent reported shortages
With the introduction of a liquid and a chew, people with ADHD gained yet another novel way to benefit from stimulant medication. That’s increasingly important these days, as the Concerta authorized-generic (most recently distributed by
